Abstracts Archive - Page 405 of 1683 - ATC Abstracts

2020 American Transplant Congress
New Onset Diabetes after Transplant (NODAT) in Hispanic Kidney Transplant Recipients: A Multi-Center Retrospective Study
R. Alsheikh¹, L. Kodali², O. Alfayez³, M. Alshibani¹, A. Basilim¹, M. Fazel⁴
¹King Abdulaziz University, Jeddah, Saudi Arabia, ²Mayo Clinic, Scottsdale, AZ, ³Qassim University, Buraydah, Saudi Arabia, ⁴University of Arizona, Tucson, AZ
*Purpose: Hispanic ethnicity is one of the reported risk factors for NODAT in kidney transplant recipients (KTR). The purpose of our study is to determine…
2020 American Transplant Congress
Transplant and Cardiovascular Outcomes in Renal Transplant Recipients with Different Pre-Transplant Cardiovascular Risk
G. Hsu¹, T. M. Sparkes¹, B. N. Reed², S. E. Gale¹, B. R. Ravichandran¹
¹University of Maryland Medical Center, Baltimore, MD, ²University of Maryland School of Pharmacy, Baltimore, MD
*Purpose: Renal transplant patients have higher cardiovascular (CV) risk compared to their peers. Pre-transplant CV risk factors may be amplified post-transplant, but little is known…
2020 American Transplant Congress
Effects of Kidney Transplantation on Cystogenesis in Kidneys Procured from a Deceased Donor with Autosomal Dominant Polycystic Kidney Disease
M. C. Chumley¹, H. Kim², D. M. Williams³, V. Kumar³, M. Mrug³
¹University of Alabama at Birmingham, Birmingham, AL, ²Radiology, University of Alabama at Birmingham, Birmingham, AL, ³Nephrology, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients are not routinely considered as kidney donors for renal transplantation. This is partially due to a concern…
2020 American Transplant Congress
Synergistic Impact of Obesity and Pre-sensitization in Kidney Transplant Recipients on the Long Term Allograft Survival
Y. Park¹, S. Lee¹, E. Ko¹, T. Ban², J. Min³, H. Yoon⁴, C. Yang¹, B. Chung¹
¹Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Eunpeyong St. Mary's Hospital, Seoul, Korea, Republic of, ³Internal Medicine, Bucheon St. Mary's Hospital, Seoul, Korea, Republic of, ⁴Internal Medicine, Incheon St. Mary's Hospital, Seoul, Korea, Republic of
*Purpose: Obesity is emerging as important health problems worldwide. In recent years, with the development of desensitization therapy, successful kidney transplantation has been performed even…
2020 American Transplant Congress
Kidney Transplantation for the Prevention of Aggravation of Peripheral Arterial Disease in the Diabetic Ischaemic Lower Limb. A Multicenter Propensity Score Matched Cohort Study in Japan
M. Taniguchi
Division of Transplant Surgery, St. Mary Hospital, Kurume, Japan
*Purpose: Japan substantially outperforms other countries in survival of patients receiving haemodialysis (HD). Unadjusted 5-year survival was 60% in Japan, 39% in the USA, and…
2020 American Transplant Congress
The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study
M. Park¹, Y. Gao¹, S. Schroeder², S. Siyahian¹, Z. Laszik¹, F. Vincenti¹
¹UCSF, San Francisco, CA, ²UC Davis, Sacramento, CA
*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in…
2020 American Transplant Congress
Pre-Donation CKD-EPI GFR is Superior to Iothalamate Split Scan Results in Predicting 6-Month Post-Nephrectomy Donor Kidney Function
J. R. Montgomery, A. Zondlak, C. S. Brown, A. Pinsky, K. Walsh, J. Kozlowski, E. A. Herriman, Y. Lu, R. S. Sung, K. J. Woodside
General Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Predicting post-donation GFR remains a challenge during living kidney donor (LKD) evaluation. Iothalamate split scans have been employed during LKD evaluation to document measured…
2020 American Transplant Congress
Efficacy and Safety Outcomes by Donor Type in De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from Transform
S. Berger¹, M. Bakr¹, F. Bemelman¹, R. Danguilan¹, H. De Fijter¹, D. Han¹, M. Kim¹, E. Mor¹, A. Patel¹, M. Hernandez Gutierrez², A. Gawai², Y. Watarai¹
¹TRANSFORM Study Group, Basel, Switzerland, ²Novartis Pharma AG, Basel, Switzerland
*Purpose: To assess the efficacy and safety outcomes in de novo renal transplant (RTx) recipients receiving everolimus with reduced-exposure calcineurin inhibitor (EVR+rCNI) versus mycophenolate with…
2020 American Transplant Congress
Risk Factors and Treatment of Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation
G. Chen, C. Wang, Z. Wu, X. Liu, Q. Li, L. Chen
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
*Purpose: Recurrent focal segmental glomerulosclerosis(FSGS) is common after kidney transplantation . We conducted a retrospective cohort study with the aim to investigating the risk factors…
2020 American Transplant Congress
Survival of Right and Left Living Donor Renal Allografts is Equivalent Even with Higher-Than-Average Rates of Right Graft Utilization
D. C. O'Brien, J. Fridell, W. C. Goggins
Surgery, Indiana University, indianapolis, IN
*Purpose: Previous studies have demonstrated comparable rates of graft survival for right and left living donor renal allografts, however such analyses have been conducted among…